Nigella sativa as an anti-inflammatory agent in asthma

Mukhtar Ikhsan, Nurul Hiedayati, Kazutaka Maeyama, Fariz Nurwidya

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)


Objective: Nigella sativa (N. sativa) has several pharmacological actions which include antioxidant, antidiabetic, anticancer, antitussive, immunomodulator, analgesic, antimicrobial, anti-inflammatory, spasmolytic, and bronchodilator. The purpose of this study is to measure the effectivity of N. sativa ethanol extract as anti-inflammation on peritoneal Wistar rat mast cells. The laboratory experiment was used to investigate the effectivity of N. sativa as an anti-inflammatory on mast cells. Six groups of mast cells were stimulated by C 48/80 to release histamine. Group 1 were without N. sativa, while group 2, 3, 4, 5, and 6 were given N. sativa with concentrations of 0.1 mg/ml, 0.2 mg/ml, 0.3 mg/ml, 0.4 mg/ml and 0.5 mg/ml, respectively. Histamine concentration was measured by high-performance liquid chromatography-fluorometry. Result: The study showed that N. sativa ethanol extract effectively inhibit histamine release from peritoneal Wistar rat mast cells proportionally to its concentration. N. sativa is effective as an anti-inflammation on mast cells by inhibition of histamine release and has no toxic effect on mast cell. N. sativa could be considered as a potential therapy for asthma therapy and prevention.

Original languageEnglish
Article number744
JournalBMC Research Notes
Issue number1
Publication statusPublished - 19 Oct 2018


  • Anti-inflammatory
  • Asthma
  • Nigella sativa


Dive into the research topics of 'Nigella sativa as an anti-inflammatory agent in asthma'. Together they form a unique fingerprint.

Cite this